Analyst Ratings for Moderna (MRNA) [Sells]
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $246.00 (Piper Sandler)
- Lowest: $83.00 (SVB Leerink)
- Average: $162.46
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$162.46 (-25.8%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
Avg. $ Target:
$162.46 (-25.8%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/1/2021 | BofA Securities | Geoff Meacham | Downgrade | Underperform (Neutral) |
N/A (N/A) |
173.16 (218.85) |
26.39% | Details |
| 9/8/2020 | SVB Leerink » Updated 5/6/2021 |
Mani Foroohar | Downgrade | Underperform (Market Perform) |
83.00 (79.00) |
62.60 (218.85) |
249.6% | Details |
